Entrant HF Cardiac Resynchronization Therapy Defibrillator (CRT-D)

Entrant™ HF CRT-D solutions use smartphone connectivity with extended therapy that you can intuitively program to make a powerful difference in the lives of your heart failure patients.

Get fast, effective CRT optimization with SyncAV CRT technology
Encourage greater patient engagement with app-based remote monitoring
Provide powerful, lasting therapy with a small, contoured design with 1.5T and 3T MR Conditional*

Description

Rx only

Intended Use: Cardiac Resynchronization Therapy Defibrillator (CRT-D) devices are intended to provide ventricular antitachycardia pacing and ventricular cardioversion/defibrillation. CRT-D devices are also intended to resynchronize the right and left ventricles.

Indications: CRT-D devices are indicated for the automated treatment of life-threatening ventricular arrhythmias. CRT-D devices are also indicated for treating symptoms in patients with congestive heart failure with ventricular dyssynchrony.

In addition, CRT-D devices with the AT/AF detection algorithm are indicated for patients with atrial tachyarrhythmias or patients at significant risk of developing atrial tachyarrhythmias.

MR Conditional CRT-Ds are conditionally safe for use in the MRI environment when used in a complete MR Conditional system and according to the instructions in the MRI-Ready Systems manual. Scanning under different conditions can result in serious patient injury, death, or device failure.

Contraindications: Contraindications to the use of the pulse generator system include ventricular tachyarrhythmias caused by transient or correctable factors such as drug toxicity, electrolyte imbalance, or acute myocardial infarction.